Guy G Brusselle Selected Research

Muscarinic Antagonists

1/2022	Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes.
1/2022	Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
1/2022	Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
1/2022	Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
2/2016	Cardiac effects of current treatments of chronic obstructive pulmonary disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guy G Brusselle Research Topics

Disease

78	Chronic Obstructive Pulmonary Disease (COPD) 02/2024 - 06/2005
44	Asthma (Bronchial Asthma) 02/2024 - 06/2005
28	Inflammation (Inflammations) 01/2023 - 03/2006
18	Pneumonia (Pneumonitis) 12/2021 - 01/2006
13	Emphysema 01/2023 - 12/2005
5	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020 - 05/2014
4	Symptom Flare Up 01/2022 - 01/2022
4	Eosinophilia 01/2020 - 04/2013
4	Respiratory Hypersensitivity 12/2018 - 03/2006
4	Body Weight (Weight, Body) 05/2015 - 06/2008
3	Heart Failure 01/2024 - 01/2014
3	Airway Remodeling 01/2023 - 01/2015
3	Obesity 01/2023 - 01/2019
3	COVID-19 04/2021 - 01/2020
3	Necrosis 01/2021 - 06/2008
3	Metaplasia 01/2017 - 01/2015
3	Airway Obstruction (Choking) 01/2016 - 06/2014
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2024 - 01/2019
2	Hypertension (High Blood Pressure) 01/2024 - 04/2021
2	Rhinosinusitis 01/2023 - 10/2021
2	Lung Diseases (Lung Disease) 11/2021 - 11/2017
2	Nasal Polyps (Nasal Polyp) 10/2021 - 01/2021
2	Atrial Fibrillation 04/2021 - 05/2006
2	Bacterial Infections (Bacterial Infection) 01/2021 - 09/2011
2	Nasopharyngitis 01/2020 - 05/2015
2	Anaphylaxis (Anaphylactic Shock) 01/2020 - 05/2015
2	Crohn Disease (Crohn's Disease) 01/2020 - 01/2015
2	Bronchiectasis 01/2017 - 01/2014
2	Genetic Risk Score 01/2017 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2016 - 01/2014
2	Obstructive Lung Diseases (Obstructive Lung Disease) 06/2015 - 01/2014
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2014 - 04/2014
2	Respiratory Tract Diseases (Respiratory Tract Disease) 05/2014 - 08/2013
2	Weight Gain 10/2010 - 10/2010
1	Respiratory Sounds (Crackle) 01/2024
1	Chronic Cough 01/2024
1	Parasitic Diseases (Parasitic Disease) 01/2023
1	Coronary Disease (Coronary Heart Disease) 04/2021

Drug/Important Bio-Agent (IBA)

33	SmokeIBA 10/2022 - 12/2005
19	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 08/2005
17	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2005
15	Messenger RNA (mRNA)IBA 01/2021 - 12/2005
11	CytokinesIBA 01/2023 - 06/2009
11	MicroRNAs (MicroRNA)IBA 12/2021 - 04/2011
10	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 04/2013
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2007
6	GoldIBA 02/2024 - 01/2007
6	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017 - 03/2011
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2016
5	Muscarinic AntagonistsIBA 01/2022 - 02/2016
5	MacrolidesIBA 01/2021 - 01/2014
4	Interleukin-5 (Interleukin 5)IBA 01/2024 - 09/2012
4	mepolizumabIBA 01/2023 - 09/2014
4	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 01/2022
4	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2022 - 01/2022
4	Interleukin-13IBA 01/2021 - 05/2011
4	GasesIBA 01/2018 - 12/2005
3	C-Reactive ProteinIBA 01/2024 - 03/2009
3	reslizumabIBA 01/2023 - 05/2015
3	Pancreatic Elastase (Elastase)IBA 01/2023 - 03/2011
3	Immunoglobulin E (IgE)IBA 01/2023 - 03/2006
3	ChemokinesIBA 12/2021 - 06/2009
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2010
3	Bronchodilator Agents (Bronchodilators)IBA 01/2019 - 01/2016
3	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 12/2018 - 02/2016
3	CateninsIBA 01/2017 - 03/2011
3	EnzymesIBA 01/2015 - 06/2010
3	LeptinIBA 08/2013 - 06/2010
3	Matrix Metalloproteinases (MMPs)IBA 10/2010 - 06/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2008 - 12/2005
2	Monoclonal AntibodiesIBA 01/2023 - 01/2021
2	Protein Kinases (Protein Kinase)IBA 01/2023 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2023 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
2	LigandsIBA 12/2021 - 10/2006
2	Transcription Factors (Transcription Factor)IBA 12/2021 - 03/2019
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 10/2013
2	ApolipoproteinsIBA 01/2021 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 10/2013
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2021
2	Interleukin-33IBA 01/2020 - 12/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2015 - 04/2014
2	activin AIBA 04/2014 - 03/2010
2	Leptin ReceptorsIBA 08/2013 - 06/2010
2	Chemokine ReceptorsIBA 06/2007 - 04/2007
1	Advanced Glycation End ProductsIBA 02/2024
1	Syntex adjuvant formulationIBA 02/2024
1	LeukotrienesIBA 01/2023
1	Omalizumab (Xolair)FDA Link 01/2023
1	dupilumabIBA 01/2023
1	benralizumabIBA 01/2023
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 10/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2021
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 12/2021
1	NitratesIBA 04/2021

Therapy/Procedure

15	Therapeutics 01/2022 - 08/2005
5	Biological Therapy 01/2022 - 01/2022
1	Drug Prescriptions 01/2024
1	Precision Medicine 01/2022